Concord Medical Services Stock Filter Stocks by Fundamentals
| CCM Stock | USD 5.00 0.56 12.61% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
| Last Reported | Projected for Next Year | ||
| Cash And Equivalents | 181 M | 230.8 M |
Concord | Cash and Equivalents |
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 806.3M | 781.0M | 555.0M | 494.1M | 356.5M | 338.7M | |
| Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.6B | 6.9B |
Concord Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Concord Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Concord Medical's managers, analysts, and investors.Environmental | Governance | Social |
Concord Fundamentals
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.044 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.90) % | ||||
| Current Valuation | 466.69 M | ||||
| Shares Outstanding | 2.82 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.10 % | ||||
| Number Of Shares Shorted | 11.4 K | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 537.4 M | ||||
| Gross Profit | (152.41 M) | ||||
| EBITDA | (313.75 M) | ||||
| Net Income | (531.02 M) | ||||
| Cash And Equivalents | 157.39 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 3.3 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (489.59) X | ||||
| Cash Flow From Operations | (276.47 M) | ||||
| Short Ratio | 2.14 X | ||||
| Earnings Per Share | (11.98) X | ||||
| Target Price | 1.2 | ||||
| Number Of Employees | 727 | ||||
| Beta | -0.27 | ||||
| Market Capitalization | 19.28 M | ||||
| Total Asset | 6.05 B | ||||
| Retained Earnings | (4.06 B) | ||||
| Working Capital | (1.33 B) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
| Net Asset | 6.05 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.98) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.